Global Infertility Treatment Market Outlook 2031
The global infertility treatment market size was valued at USD 1.62 billion in 2022 and is expected to surpass USD 3.27 billion by 2031 expanding at a CAGR of 8.1% during the forecast period, 2023–2031. Increasing public-private investments, funds, and grants, as well as a declining fertility rate and a growing number of fertility clinics around the world, are the primary factors driving infertility treatment market.
Infertility refers to a person's inability to reproduce in a natural way. Infertility can be caused by a variety of factors. Increased maternal age, problems related to ovulation, blockage or tubal occlusion, sexually conveyed infections, immunological infertility, heredity, and infertility induced by malefactors are few of the reasons.
Infertility Treatment Market Trends, Drivers, Restraints, and Opportunities:
- Factors such as decreased worldwide fertility and increasing number of fertility clinics and hospitals around the globe are expected to rise the infertility treatment market.
- Growing advancements in technology, rising public-private sector investments and corporate funding is anticipated to drive the market during the forecast period.
- Infertility disorders in men and women are caused by a variety of causes, including a constant shift to a sedentary lifestyle, delayed pregnancy, and poor fetal care, which is projected to boost the market in the coming years.
- High price associated with the process for treating infertility is a major factor expected to hinder the market growth during the forecast period.
- Lack of experienced personnel and strict government restrictions are two restraint factors that can limit the growth of the infertility treatment market in the coming years.
- Emerging markets such as India, China, Brazil, and Mexico are anticipated to offer considerable growth opportunities for the market players.
Scope of The Infertility Treatment Market Report
The report on the global infertility treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title |
Infertility Treatment Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year
|
2022
|
Historic Data
|
2016-2021
|
Forecast Period
|
2023-2031
|
Segmentation
|
Types (Equipment, Media & Consumables, and Accessories), Procedures (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Others), Patient Types (Female Infertility Treatment and Male Infertility Treatment), End-Users (Fertility Centres, Hospitals & Surgical Clinics, Cryobanks, and Research Institutes)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players covered in the Report
|
Vitrolife, CooperSurgical, Inc., Cook, Thermo Fisher Scientific, FUJIFILM Irvine Scientific., Rocket Medical plc., Hamilton Thorne, Inc., MEDGYN PRODUCTS, INC., Nidacon International AB, and InVitroCare Inc.
|
Global Infertility Treatment Market Segment Insights
The equipment segment is expected to hold major market share during the forecast period
Based on the products, the market is divided into equipment, media & consumables, and accessories. The equipment segment is expected to account for a key share of the market during the forecast period owing to the presence of well-established companies with a strong product portfolio and increasing technological advancements in the field of infertility treatment.
The assisted reproductive technology segment is projected to account for a significant market share
In terms of procedure, the infertility treatment market is segregated into assisted reproductive technology, artificial insemination, fertility surgeries, and others. The assisted reproductive technology segment is projected to account for a significant share of the market during the forecast period. The rising awareness of assisted reproductive technology (ART), and increasing worldwide acceptance of ART are projected to boost the segment.
The female infertility treatment segment is estimated to grow at a rapid pace
Based on the patient types, the infertility treatment market is bifurcated into female infertility treatment and male infertility treatment. The female infertility treatment segment is estimated to grow at a rapid pace during the forecast period. The female infertility treatment segment is developing due to declining female fertility rates, growing availability of various fertility treatment options, and rising number of fertility facilities around the world.
The fertility centers segment is anticipated to expand at a high CAGR during the forecast period
In terms of end-users, the infertility treatment market is divided into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is anticipated to expand at a high CAGR during the forecast period. Rising government initiatives to create reproductive clinics, significant international healthcare providers' initiatives to establish fertility centers, and growing popularity of IVF and ICSI treatment globally are projected to drive the market.
North America is anticipated to dominate the market
On the basis of regions, the global infertility treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during forecast period. Increased investments in R&D, high awareness, favorable rules & regulations, reimbursement policies by governmental bodies, increase in health care spending, and other factors contribute to the region’s significant growth in the infertility treatment market.
The market in Asia Pacific is expected to grow at a rapid rate during the projected period. Increased population and awareness, as well as increased governmental and private sector investment support are estimated to propel the market.
Segments
By Product
- Equipment
- Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Media & Consumables
- Accessories
By Procedure
- Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Morphologically Selected Sperm Injection
- Gamete Donation
- Intracytoplasmic Sperm Injection
- Surrogacy
- Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
- Fertility Surgeries
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction
- Vasovasostomy
- Vasoepididymostomy
- Others
By Patient type
- Female Infertility Treatment
- Male Infertility Treatment
By End-User
- Fertility Centers
- Hospitals & Surgical Clinics
- Cryobanks
- Research Institutes
By Regions
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
By Key Players
- Vitrolife
- CooperSurgical, Inc
- Cook
- Thermo Fisher Scientific
- FUJIFILM Irvine Scientific
- Rocket Medical plc
- Hamilton Thorne, Inc
- MEDGYN PRODUCTS, INC
- Nidacon International AB,
- InVitroCare Inc
Competitive Landscape
Some of the key players in the infertility treatment market include Vitrolife, CooperSurgical, Inc., Cook, Thermo Fisher Scientific, FUJIFILM Irvine Scientific., Rocket Medical plc., Hamilton Thorne, Inc., MEDGYN PRODUCTS, INC., Nidacon International AB, and InVitroCare Inc.